A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)

NCT01354990 · clinicaltrials.gov ↗

COMPLETED

Status

2974

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Sitagliptin (JANUVIA®)

Sponsor

Merck Sharp & Dohme LLC